Part of the work at Abliva consists of making the company’s activities visible in different public contexts, partly to increase understanding of the enormous medical needs of people with primary mitochondrial disease, but also to increase interest in the company among potential investors or partners.
Conference call on the positive interim analysis of FALCON 19 July 2024
BioStock Global Forum 29 – 30 May 2024
Abliva Virtual KOL Event 21 May 2024
BioStock Life Science Summit 25 – 26 October 2023
ABGSC Life Science Summit 30 – 31 May 2023
Penser Market Bolagsdag 25 May 2023
BioStock Investor Meeting 16 March 2023
Aktiespararna’s Stora Aktiedagen Stockholm 29 November 2022
Aktiespararna’s Aktiedagen Lund 26 September 2022
Aktiespararna’s Temadag Life Science 31 August 2022
Bioblast 2022, Innsbruck, Austria 29 – 30 June 2022
BioStock interview on SEK 200 million financing round June 1, 2022
Mitochondria-Targeted Drug Development 22 – 24 Feb 2022.
For more of our videos, please visit our YouTube channel:
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Read our cookie policy